Publications by authors named "Michael Arning"

Claim this Profile
A
Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial.
Helmut Oettle, Peter Neuhaus, Andreas Hochhaus, Jörg Thomas Hartmann, Klaus Gellert, Michael B Arning

JAMA· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeated short-term use of eltrombopag in patients with chronic immune thrombocytopenia (ITP).
James B Bussel, Mansoor N Saleh, Sandra Y Vasey, Bhabita Mayer, Michael Arning

Br J Haematol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study.
Mansoor N Saleh, James B Bussel, Gregory Cheng, Oliver Meyer, Christine K Bailey, Michael Arning

Blood· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study.
Gregory Cheng, Mansoor N Saleh, Claus Marcher, Sandra Vasey, Bhabita Mayer, Michael Arning

Lancet· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial.
James B Bussel, Drew Provan, Tahir Shamsi, Gregory Cheng, Bethan Psaila, Michael Arning

Lancet· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura.
James B Bussel, Gregory Cheng, Mansoor N Saleh, Bethan Psaila, Lidia Kovaleva, Michael Arning

N Engl J Med· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical costs associated with non-Hodgkin's lymphoma in the United States during the first two years of treatment.
Lucie Kutikova, Lee Bowman, Stella Chang, Stacey R Long, Michael Arning

Leuk Lymphoma· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of pemetrexed for second-line treatment of transitional cell cancer of the urothelium.
Christopher J Sweeney, Bruce J Roth, Fairooz F Kabbinavar, David J Vaughn, Michael Arning

J Clin Oncol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer.
Hans von der Maase, Lisa Sengelov, James T Roberts, Sergio Ricci, Luigi Dogliotti, Michael Arning

J Clin Oncol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A report on serious pulmonary toxicity associated with gemcitabine-based therapy.
Debasish F Roychowdhury, Catherine A Cassidy, Patrick Peterson, Michael Arning

Invest New Drugs· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis